סינגפור -
אנגלית -
HSA (Health Sciences Authority)
monurol sachet 3 gsachet
united italian trading corporation (private) limited - fosfomycin tromethamol eqv fosfomycin - granule, for suspension - 3 g/sachet - fosfomycin tromethamol eqv fosfomycin 3 g/sachet
מלטה -
אנגלית -
Malta Medicines Authority
ketonal 25mg granules for oral solutions in sachets
midas pharma gmbh rheinstrasse 49, 55218 ingelheim, germany - ketoprofen - granules for oral solution - ketoprofen 25 mg - antiinflammatory and antirheumatic products
מלטה -
אנגלית -
Malta Medicines Authority
ketonal 50mg granules for oral solutions in sachets
midas pharma gmbh rheinstrasse 49, 55218 ingelheim, germany - ketoprofen - granules for oral solution - ketoprofen 50 mg - antiinflammatory and antirheumatic products
מלטה -
אנגלית -
Malta Medicines Authority
ketofixal 25mg granules for oral solutions in sachets
midas pharma gmbh rheinstrasse 49, 55218 ingelheim, germany - ketoprofen - granules for oral solution - ketoprofen 25 mg - antiinflammatory and antirheumatic products
מלטה -
אנגלית -
Malta Medicines Authority
ketofixal 50mg granules for oral solutions in sachets
midas pharma gmbh rheinstrasse 49, 55218 ingelheim, germany - ketoprofen - granules for oral solution - ketoprofen 50 mg - antiinflammatory and antirheumatic products
אוסטרליה -
אנגלית -
Department of Health (Therapeutic Goods Administration)
kalydeco ivacaftor 25 mg granules sachet
vertex pharmaceuticals australia pty ltd - ivacaftor, quantity: 25 mg - granules - excipient ingredients: lactose monohydrate; hypromellose acetate succinate; croscarmellose sodium; sodium lauryl sulfate; silicon dioxide; magnesium stearate; mannitol; sucralose - kalydeco is indicated for the treatment of cystic fibrosis (cf) in patients aged 4 months and older who have at least one mutation in the cftr gene that is responsive to ivacaftor potentiation based on clinical and/or in vitro assay data(see section 4.4 special warnings and precautions for use, and section 5.1 pharmacodynamic properties).
אוסטרליה -
אנגלית -
Department of Health (Therapeutic Goods Administration)
kuvan sapropterin dihydrochloride 500 mg oral powder sachet
biomarin pharmaceutical australia pty ltd - sapropterin dihydrochloride, quantity: 500 mg - powder, oral - excipient ingredients: mannitol; potassium citrate; sucralose; ascorbic acid - kuvan is indicated for the treatment of hyperphenylalaninemia (hpa) in sapropterin-responsive adult and paediatric patients with phenylketonuria (pku) or tetrahydrobiopterin (bh4) deficiency (see section 4.2 dose and method of administration for definition of sapropterin responsiveness)
אוסטרליה -
אנגלית -
Department of Health (Therapeutic Goods Administration)
kuvan sapropterin dihydrochloride 100 mg oral powder sachet
biomarin pharmaceutical australia pty ltd - sapropterin dihydrochloride, quantity: 100 mg - powder, oral - excipient ingredients: mannitol; potassium citrate; sucralose; ascorbic acid - kuvan is indicated for the treatment of hyperphenylalaninemia (hpa) in sapropterin-responsive adult and paediatric patients with phenylketonuria (pku) or tetrahydrobiopterin (bh4) deficiency (see section 4.2 dose and method of administration for definition of sapropterin responsiveness)
אירלנד -
אנגלית -
HPRA (Health Products Regulatory Authority)
okitask 25 mg coated granules in sachet
dompé farmaceutici s.p.a. - ketoprofen lysine - coated granules in sachet - 25 milligram(s) - ketoprofen
אוסטרליה -
אנגלית -
Department of Health (Therapeutic Goods Administration)
molaxole powder for oral solution sachet
viatris pty ltd - sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; macrogol 3350, quantity: 13.125 g - solution, powder for - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of chronic constipation. molaxole is also effective in resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum and/or colon confirmed by physical examination of the abdomen and rectum.